Efficacy and Safety of 500mg of Fulvestrant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00585507
Recruitment Status : Active, not recruiting
First Posted : January 3, 2008
Last Update Posted : February 12, 2018
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Massachusetts General Hospital
Lowell General Hospital
University of Colorado, Denver
University of Maryland Greenebaum Cancer Center
South Shore Hospital
Information provided by (Responsible Party):
Steven Come, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018